Stephen Nadeau is a graduate of MIT and the University of Florida College of Medicine. He has published broadly in the fields of cognitive and behavioral neurology, cognitive neuroscience, computational neuroscience, neurorehabilitation, and the opioid crises. He has conducted many small randomized controlled trials and been on the leadership teams of two Phase III trials. His clinical practice has centered on patients with cognitive impairment of many etiologies, including Alzheimer’s disease.